Page 3 - Best Leukemia doctors: TOP 82 doctors

Dr. Eckhart Weidmann heads the Hematology sector at Nordwest Clinic, specializing in blood disorder treatment with over 36 years of experience of practice.

• One of the best non-Hodgkin lymphoma doctors
• Professor with extensive academic and clinical expertise
• Focuses on complex blood disorders

Listed among Forbes' best doctors in Israel, Dr. Gal Goldstein leads the Pediatric Oncology and Hemato-Oncology Department at Hadassah Medical Center.

• Over 27 years of experience specializing in pediatric hemato-oncology
• Expert in haploidentical bone marrow transplantation
• Focus on retinoblastoma and precision medicine
• Member of four international pediatric oncology associations
• Trained at Tel Aviv University

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Professor Zila Zuckerman is a dedicated hematology and transplantology specialist at Rambam Medical Center.

• Expert in adult and pediatric blood cancers
• Focuses on bone marrow transplantation for leukemia
• Part of a major academic medical center team

Leads the Hematology Department at Hadassah Medical Center, where she specializes in advanced treatments for blood cancers.

• Professor with over three decades of experience in malignant blood diseases
• Trained for three years at Memorial Sloan-Kettering Cancer Center in New York
• Expert in bone marrow transplant and novel gene therapies
• First woman to serve as Dean of Hadassah School of Medicine
• Received the Healing with the Heart Award for exceptional patient care

Dr. Stepensky has performed over 3,500 bone marrow transplants and was recognized by Forbes as one of the best doctors.

• Specializes in treating children with leukemia and rare blood cancers
• 28 years of experience of dedicated practice in pediatric hematology
• Patients and parents call her the doctor who 'transplants life'

Dr. Spielberg is an oncohematologist specializing in blood cancers at Assuta Medical Center.

• Expertise focused specifically on leukemia and other blood disorders
• Based at Israel's prominent private hospital, Assuta Medical Center
• Provides integrated cancer care with access to advanced diagnostics

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Prof. Bosch leads global research in Chronic Lymphocytic Leukemia (CLL), with 80+ active clinical trials advancing new treatments.

• Specializes in CLL and lymphoproliferative disorders since 2000
• President of the Spanish CLL study group (GELLC)
• Published 100+ articles in top journals like NEJM and Nature Medicine
• Fellowship at Columbia University's Institute of Cancer Genetics

Prof. Dr. Serdar Bedii Omay has published 65+ scientific articles on hematology and bone marrow transplantation, with extensive experience from Hacettepe and Ege University.

• Specialized in hematology at Japan's Mie Medical School
• Professor of Hematology at Karadeniz Technical University
• Over 36 years of experience of experience in hematology
• Authored 112 meeting papers and 34 conference presentations

Prof. Baytan specializes in childhood leukemia and bone marrow transplants at Emsey Hospital, with a focus on pediatric hematology.

• Over 34 years of experience of experience in pediatric hematology and oncology
• Published 15 articles in international journals on childhood cancers
• Expertise in leukemia, lymphoma, and bleeding disorders in children
• Academic professor with extensive research contributions

Specializes in chronic leukemia and myeloproliferative diseases at Liv Hospital Ulus, with extensive research and clinical focus.

• Board-certified hematologist with over 36 years of experience of experience
• Published 32 articles in international peer-reviewed journals
• Member of the Turkish Society of Hematology
• Holds a position on the Board of Directors for The Society of Hematological Education and Research